BioXcel Therapeutics Competitors and Similar CompaniesClear all
BioXcel Therapeutics's competitors and similar companies include Merus.
 BioXcel Therapeutics BioXcel Therapeutics is a biopharmaceutical company that focuses on artificial intelligence for neuroscience. |  Merus Merus is a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics with the goal of treating and potentially curing cancer patients. | |
Founding Date | Founding Date 2017 | Founding Date 2003 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations New Haven, US HQ | Locations Utrecht, NL HQ Cambridge, US |
Employees | Employees 29 | Employees 260 |
Valuation ($) | Valuation ($) 29 m | Valuation ($) 3.6 b |
Financial | ||
Revenue (est.) | Revenue (est.) $642k (FY, 2025) | Revenue (est.) $36.1m (FY, 2024) |
Cost of goods | Cost of goods $164k (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit $478k (FY, 2025) | Gross profit $36.1m (FY, 2024) |
Net income | Net income ($69.9m) (FY, 2025) | Net income ($215.3m) (FY, 2024) |
For sources of this data, please see the company profile
View Company Profiles
Merus
HQ
Utrecht, NL
Employees
260
Merus is a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics with the goal of treating and potentially curing cancer patients.
View company